AI-generated summary
The authors studied eight women with long-term melasma using a split-face design, treating one side with a 1,064-nm Q-switched Nd:YAG laser plus ultrasonic vitamin C and the other side with laser alone over four sessions. They report significant improvement on the vitamin C side compared with laser monotherapy, with no rebound or post-inflammatory hyperpigmentation at three months.
- Participants
- 8
- Who or what was studied
- Eight patients aged 32 to 45 years (mean 37) with long-term melasma, mostly dermal or mixed type
- Limits stated in the abstract
- The study included only eight patients and the abstract reports a visual analog score without describing blinding or a long-term follow-up beyond three months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.